Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

URRE, ENZ, MAGS, ORFG, RUTH - Stock Report From DrStockPick.com!

drstock-2-3

signup3m

http://pennyomega.com/img/enz.jpg

Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.

The business activities of Enzo Biochem are performed by the company’s three wholly owned subsidiaries . . . Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. Such activities include research and development, manufacturing and marketing of biomedical research products and tools through Enzo Life Sciences and research and development of therapeutic products through Enzo Therapeutics and the operation of a regional clinical reference laboratory through Enzo Clinical Labs.

Enzo Biochem, Inc. reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

The Company's financial condition remained strong, with working capital of $42.1 million. As of October 31, 2010, cash and cash equivalents, plus short term investments in US Treasury Bills, totaled $31.6 million. At November 30, 2010 Enzo’s cash, and cash equivalents and short-term investments were $33.9 million, which exceeded the July 31, 2010 balance by $0.3 million. Cash utilization in operations declined year over year by approximately $1 million to $1.8 million principally due to the reduced loss in the 2011 period. Management’s plan is to move towards being cash flow positive from operations in calendar 2011. There was no debt.

Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including esoteric tests, to the medical community. Since our founding in 1976, our strategic focus has been on the development of enabling technologies in the life sciences field.

Enzo Life Sciences develops, produces and markets proprietary labeling and detection products for gene sequencing, genetic analysis and immunological research, among others. Its catalog of over 30,000 products serves the molecular biology, drug discovery and pathology research markets worldwide.

Enzo Clinical Labs provides laboratory services for a growing roster of physicians in the New York Metropolitan area, Eastern Pennsylvania and New Jersey. Its tests include, in addition to routine tests, capabilities for detecting molecular infection disease, molecular oncology, autoimmune disorders and genetics. Enzo Clinical Labs also provides clinical diagnostic services that allow Enzo to capitalize on its extensive advanced molecular and cytogenetic capabilities and the broader trends in predictive and personalized diagnostics.

Enzo Therapeutics is a biopharmaceutical venture that has developed multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. It has focused its efforts on developing treatment regimens for diseases and conditions for which current treatment options are ineffective, costly, and/or cause unwanted side effects.

In the course of the company’s research and development activities, Enzo has also developed a substantial portfolio of intellectual property asset with patent coverage across a number of key technologies

****************************************

orfg_logo203x87

Orofino Gold Corp. (ORFG.PK) is a China based gold producer with one producing gold mine in Colombia and an option on a strong portfolio of small producers and development/exploration assets in Colombia.

La Azul is one producing artesanal mine in the Senderos de Oro area controlled by Orofino, it is a mixed sequence of predominantly volcanic rocks with the vien systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz viens.

La (Mina) Azul/La Estrella:

* Assays of copper-gold samples ran in excess of 40g/t gold, and contain up to 8% copper, bornite and cholcopyrite.
* The interpretation and the prospectivity of this concession has been confirmed by an Orofino Qualified Person (as described by the 43-101 compliant standard).
* The area is the site of economic mining activity and it is unlikely that the true grade of gold mineralization has been determined by the crude benefication methods employed by the resident miners.
* The existing process of using mercury amalgamation to collect the free gold after grinding, followed by cyanide leach of the crushed material would not, for example, liberate gold tied up in the sulphides.

About Colombia:

# Stable democracy for over 150 years
# Growing, educated work force
# Good infrastructure
# No history of nationalizing foreign holdings or defaulting on foreign debt
# Northern extension of the mineral-rich Andes Cordillera
# Current government promoting rapid growth in mining sector
# Juan Manuel Santos recently elected President (former Defense Minister during Alvaro Uribe’s administration, will continue to promote foreign investment and mineral resource development)

****************************************

Ruth's Hospitality Group Inc. (Nasdaq:RUTH) reported preliminary unaudited sales results for its fourth quarter ended December 26, 2010. Company-owned restaurant sales, excluding franchise and other income, increased 8.0% to $90.4 million for the fourth quarter of 2010 versus $83.8 million for the fourth quarter of 2009. Company-owned comparable restaurant sales for Ruth's Chris Steak House increased 9.2%. The Company expects to release unaudited financial results for its fourth quarter ended December 26, 2010 on February 18, 2011.

Ruth’s Hospitality Group, Inc., together with its subsidiaries, operates restaurants in the United States and internationally. It operates the Ruth’s Chris Steak House, Mitchell’s Fish Market, Columbus Fish Market, Mitchell’s Steakhouse, and Cameron’s Steakhouse restaurant concepts in the full-service dining industry.

****************************************

Magal Security Systems Ltd. (Nasdaq:MAGS) announced that it has received a $2.6 million order for an integrated solution to secure a seaport in West Africa. This is the second order received within the past few weeks for a port security solution in the region. Magal S3 will deliver an integrated solution including a variety of security systems, including DTR (taut wire) which will be deployed on a wall running several kilometers along the coastline, gates and access control, radio communications, static and PTZ cameras.

Magal Security Systems Ltd., together with its subsidiaries, engages in the development, manufacture, marketing, and sale of computerized security systems used to detect and deter human intrusion for civilian and military markets. The company offers perimeter security systems that enable customers to monitor, limit, and control access by unauthorized personnel to specific regions or areas.

****************************************

Uranium Resources, Inc. (Nasdaq:URRE) announced that it has completed an agreement to explore 53,500 acres in Kenedy County, Texas, for three years, with an option to lease the acreage for uranium production. The lease would have a primary term of eight years after lease commencement.

Uranium Resources, Inc. engages in the acquisition, exploration, development, and mining of uranium properties, using the in situ recovery or solution mining process. It owns developed and undeveloped uranium properties in South Texas; and undeveloped uranium properties in New Mexico.

**********************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising .

drstbc